Sincalide
Product Description
Biophore Pharma INC.
-
US
-
2015On CPHI since
-
3Certificates
Company types
Specifications
Biophore Pharma INC.
-
US
-
2015On CPHI since
-
3Certificates
Company types
More Products from Biophore Pharma INC. (57)
-
Product Gadobenate dimeglumine
Gadobenate dimeglumine is an Diagnostic Agent which is indicated for the treatment of Magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults.
Biophore's Gadobenate dimeglumine: API Developed, Stringent control on inorganic impurities, ... -
Product Gadobutrol
Gadobutrol is an MRI Contrast Agent.
Biophore's Gadobutrol: Product meets the specifications of the EP draft monograph, All impurities below 0.05, Stringent control on sodium and chloride. -
Product Liothyronine Sodium
Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.
Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed
-
Product Methazolamide
Methazolamide Anti Coagulant indicated for the treatment of ocular conditions.
Biophore's Methazolamide: -
Product Nadolol
Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.
Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016. -
Product Palbociclib
Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2.
-
Product Zofenopril
Zofenopril is an Antihypertensive agent.
Biophore's Zofenopril: USFDA approved manufacturing facility, US DMF Filed [ # 026446 ]. -
Product Tipiracil
Tipiracil is an Thymidine phosphorylase inhibitor/nucleoside metabolic inhibitor used to treatment of metastatic colorectal cancer. -
Product Trifluridine
Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis. -
Product DOTA
DOTA is an Chelating agent
Biophore's DOTA: All impurities below 0.07 (% w/w), Stringent control on sodium and chloride, Stable at room temperature, Commercialized product for Europe. -
Product DTPA
DTPA is an Chelating agent
Biophore's DTPA: Stringent control on Iron content, All impurities below 0.01 -
Product Trientine
Trientinen is indicated for the treatment of patients with Wilson's disease who are intolerant of penicillamine.
Biophore's Trientine: DMF Filed
Biophore Pharma INC. resources (1)
-
Video Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023
Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance